ObesityNCT03653468
Exercise for Preventing the Metabolic Syndrome in Latinoamerican Amerindians
A study testing Concurrent training (CT) in people with Obesity and Cardiovascular Risk Factor, run by Universidad Santo Tomas at 1 site in Chile.
Trial summary
Despite exercise training decrease blood fasting glicaemy in 'average' terms, there is a wide inter-individual variability after exercise training explored mainly in adults but not in adults with prediabetes comorbidities. Read more about this study
- Who is it for?
- Ages 30 to 59 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Obesity, Cardiovascular Risk Factor, Physical Activity
- What is being tested?
- Concurrent training (CT)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 28 participants
- Where
- 1 siteChile
- Study dates
- 1 Jan 2018to 25 Aug 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 59 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Written informed consent
- Interested in improving health and fitness
Who cannot join
- Cardiovascular contraindications to exercise
- History of stroke, asthma or chronic obstructive pulmonary disease, muscle-skeletal disorders
- Smoking
- A compliance rate to the exercise program ≥ 70% was required for the participants in the intervention group to be included in the statistical analyses.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Similar Improvements in Cardiometabolic Risk Factors for Preventing the Metabolic Syndrome in Latinoamerican Amerindians After 12-weeks of Concurrent Training
Despite exercise training decrease blood fasting glicaemy in 'average' terms, there is a wide inter-individual variability after exercise training explored mainly in adults but not in adults with prediabetes comorbidities. Thus, is yet unknown the effects and influence of the concurrent training (CT) eliciting responders (R) and non-responders (NR) cases (i.e., percentage of subjects who experienced a non-change/worsened response after training in some metabolic outcomes).
- Conditions
- Obesity, Cardiovascular Risk Factor, Physical Activity
- Being tested
- Concurrent training (CT)
- Medical subject headings
- Obesity, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Concurrent training (CT)Behavioural
The core part of each session included resistance training (RT) followed by aerobic training exercises (for 50 and 30 minutes, respectively) and was preceded and followed by a 5-minute warm-up and cool-down with callisthenic movements.
| Study group | Role | What they receive |
|---|---|---|
| Control group | No intervention | No-exercise |
| Endurance training plus resistant training | Experimental | Concurrent training Receives: Behavioral: Concurrent training (CT) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Fasting glucose
Change from Baseline in fasting glucose
Measured: Baseline and 20-weeks immediately after the interventions ends
Total cholesterol
Change from baseline in Total cholesterol
Measured: Baseline and 20-weeks immediately after the interventions ends
Blood pressure
Change from baseline in Blood pressure
Measured: Baseline and 20-weeks immediately after the interventions ends
Secondary outcomes (6)
Body mass
Change from Baseline in body mass
Measured: Baseline and 20-weeks immediately after the interventions ends
Waist circumference
Change from Baseline in waist circumference
Measured: Baseline and 20-weeks immediately after the interventions ends
Fat mass
Change from Baseline in fat mass
Measured: Baseline and 20-weeks immediately after the interventions ends
Lean mass
Change from Baseline in lean mass
Measured: Baseline and 20-weeks immediately after the interventions ends
Heart rate at rest
Change from Baseline in heart rate at rest
Measured: Baseline and 20-weeks immediately after the interventions ends
Six minutes walking test
Change from Baseline in six minutes walking test
Measured: Baseline and 20-weeks immediately after the interventions ends
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Aug 2018
- Study start1 Jan 2018
- Primary completion28 May 2018
- Study completion25 Aug 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Behavioral
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 28 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidad Santo Tomas
- Sponsor type
- University, hospital or other
- Collaborators
- Universidad del Rosario, Universidad Pública de Navarra, Healthcare Center Tomas Rojas, Universidad de Los Lagos
- Responsible party
- Sponsor
- Investigators
- Cristian Alvarez, PhD, Principal investigator, Universidad de Los Lagos
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03653468
- Sponsor's protocol ID
- 28082018
- Status last verified
- Aug 2018
- First submitted
- 28 Aug 2018
- Last updated
- 31 Aug 2018
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Statistical Analysis Plan
Study at a glance
From the registry record, last updated by the sponsor on 31 Aug 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Similar Improvements in Cardiometabolic Risk Factors for Preventing the Metabolic Syndrome in Latinoamerican Amerindians After 12-weeks of Concurrent Training
- ClinicalTrials.gov ID
- NCT03653468
- Acronym / sponsor ID
- 28082018
- Conditions
- Obesity, Cardiovascular Risk Factor, Physical Activity
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 28 participants (actual)
- Lead sponsor
- Universidad Santo TomasUniversity, hospital or other
- Collaborators
- Universidad del Rosario, Universidad Pública de Navarra, Healthcare Center Tomas Rojas, Universidad de Los Lagos
- Study start
- 1 Jan 2018 (actual)
- Primary completion
- 28 May 2018 (actual)
- Study completion
- 25 Aug 2018 (actual)
- First posted
- 31 Aug 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Despite exercise training decrease blood fasting glicaemy in 'average' terms, there is a wide inter-individual variability after exercise training explored mainly in adults but not in adults with prediabetes comorbidities. Thus, is yet unknown the effects and influence of the concurrent training (CT) eliciting responders (R) and non-responders (NR) cases (i.e., percentage of subjects who experienced a non-change/worsened response after training in some metabolic outcomes).
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 2
- Model description
- Behavioral
| Arm | Type | Receives |
|---|---|---|
| Control group | No intervention | –No-exercise |
| Endurance training plus resistant training | Experimental | Behavioral: Concurrent training (CT)Concurrent training |
Who may qualify
- Ages
- 30 to 59 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- Written informed consent
- Interested in improving health and fitness
Key exclusion criteria (4 listed)
- Cardiovascular contraindications to exercise
- History of stroke, asthma or chronic obstructive pulmonary disease, muscle-skeletal disorders
- Smoking
- A compliance rate to the exercise program ≥ 70% was required for the participants in the intervention group to be included in the statistical analyses.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Concurrent training (CT)The core part of each session included resistance training (RT) followed by aerobic training exercises (for 50 and 30 minutes, respectively) and was preceded and followed by a 5-minute warm-up and cool-down with callisthenic movements. | Behavioural | Endurance training plus resistant training |
Primary outcome
Fasting glucose
Time frame: Baseline and 20-weeks immediately after the interventions ends
Change from Baseline in fasting glucose
Total cholesterol
Time frame: Baseline and 20-weeks immediately after the interventions ends
Change from baseline in Total cholesterol
Blood pressure
Time frame: Baseline and 20-weeks immediately after the interventions ends
Change from baseline in Blood pressure
6 secondary outcomes
Body mass
Time frame: Baseline and 20-weeks immediately after the interventions ends
Waist circumference
Time frame: Baseline and 20-weeks immediately after the interventions ends
Fat mass
Time frame: Baseline and 20-weeks immediately after the interventions ends
Lean mass
Time frame: Baseline and 20-weeks immediately after the interventions ends
Heart rate at rest
Time frame: Baseline and 20-weeks immediately after the interventions ends
Six minutes walking test
Time frame: Baseline and 20-weeks immediately after the interventions ends
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Aug 2018.
- Individual participant dataSharing planned: No. Statistical Analysis Plan
Related trials for Obesity
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Cristian Alvarez, PhD principal investigator
Universidad de Los Lagos
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Concurrent training (CT) in people with Obesity and Cardiovascular Risk Factor, run by Universidad Santo Tomas at 1 site in Chile.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Fasting glucose (time frame: Baseline and 20-weeks immediately after the interventions ends). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2018.